AbbVie

7 drugs that raised eyebrows in Q3
7 drugs that raised eyebrows in Q3
Biopharma Dive
Sanofi
Dupixent
Roche
Herceptin
AbbVie
Humira
Regeneron
Repatha
Clovis Oncology
Rubraca
GSK
Shingrix
Eli Lilly
Trulicity
Flag link:
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
Fierce Pharma
AbbVie
Orilissa
FDA
uterine fibroids
Neurocrine
Flag link:
AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's
AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's
Endpoints
targeted protein degradation
AbbVie
Mission Therapeutics
Alzheimer's disease
Parkinson's Disease
Flag link:
AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries
AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries
Fierce Pharma
AbbVie
hepatitis C
Mavyret
Medicines Patent Pool
Flag link:
Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit
Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit
RAPS.org
Boehringer Ingelheim
AbbVie
Humira
patents
biosimilars
Flag link:
AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point
AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point
Endpoints
AbbVie
San Francisco
Oyster Point
biotech
Flag link:
Bristol-Myers Squibb snags quick Empliciti combo nod in multiple myeloma
Bristol-Myers Squibb snags quick Empliciti combo nod in multiple myeloma
Fierce Pharma
Bristol-Myers Squibb
AbbVie
Empliciti
FDA
Multiple Myeloma
Celgene
Pomalyst
Flag link:
AbbVie staves off 6th Humira biosimilar in US
AbbVie staves off 6th Humira biosimilar in US
Biopharma Dive
AbbVie
Humira
biosimilars
Momenta Pharmaceuticals
Flag link:
Excellent quarter from AbbVie, but market still skeptic about pipeline
Excellent quarter from AbbVie, but market still skeptic about pipeline
GoinPharma
AbbVie
earnings
Imbruvica
Flag link:
AbbVie Follows Trend of Big Pharma Setting Office-Labs in Biotech Clusters
AbbVie Follows Trend of Big Pharma Setting Office-Labs in Biotech Clusters
BioSpace
AbbVie
San Francisco
biotech clusters
Bay Area
Flag link:
AbbVie says global Humira market eroding faster than expected
AbbVie says global Humira market eroding faster than expected
BioCentury
AbbVie
Humira
Flag link:
AbbVie lifts profit target after cancer drug powers quarterly beat
AbbVie lifts profit target after cancer drug powers quarterly beat
Yahoo/Reuters
AbbVie
earnings
Flag link:
Roche and AbbVie Push Towards First-Line CLL Treatment
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Roche
Genentech
AbbVie
clinical trials
Venclexta
Gazyva
CLL
chronic lymphocytic leukemia
Flag link:
Novartis wins US nod for Humira biosimilar, but focus now on Europe
Novartis wins US nod for Humira biosimilar, but focus now on Europe
Biopharma Dive
Novartis
Hyrimoz
biosimilars
Humira
AbbVie
FDA
Flag link:
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
Flag link:
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
Motley Fool
AbbVie
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
Abbott, AbbVie settle TriCor marketing case for $25 million
Abbott, AbbVie settle TriCor marketing case for $25 million
Yahoo/Reuters
Abbott Labs
AbbVie
kickbacks
TriCor
Flag link:
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
Pharmaforum
NICE
AbbVie
Venclyxto
Roche
Rituxan/MabThera
CLL
Flag link:
AbbVie Takes Over Galapagos Cystic Fibrosis Collaboration Instead of Walking Away
AbbVie Takes Over Galapagos Cystic Fibrosis Collaboration Instead of Walking Away
BioSpace
AbbVie
Galapagos
cystic fibrosis
Flag link:
AbbVie rheumatoid arthritis drug succeeds in late stage trial
AbbVie rheumatoid arthritis drug succeeds in late stage trial
Yahoo/Reuters
AbbVie
clinical trials
rheumatoid arthritis
Upadacitinib
Flag link:

Pages